Literature DB >> 30779678

Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.

Wei Qin1,2,3, Yao Wang1, Tao Yang1, Xiao-Kang Xu1, Xiang-Mei Meng1, Chang-Jun Zhao4, Shao-Yi Li4, Shao-Yu Xie1, Kai-Chun Li1, Hong Su3.   

Abstract

In 2016, an outbreak of mumps occurred in a primary school in China with a student population having high vaccination coverage. An unmatched case-control study was performed to identify risk factors contributing to this outbreak, and a retrospective cohort study was conducted to evaluate the effectiveness of mumps-containing vaccine (MuCV). A total of 97 cases were identified during the outbreak, and the overall attack rate was 8.2%. Among students with confirmed vaccination status, 90% had received at least one dose of MuCV. Cases were more likely than non-cases to report taking the school bus during the epidemic period (adjusted OR = 2.3, 95% CI: 1.4-3.7). Vaccine effectiveness (VE) was higher for two-dose MuCV (76%, 95% CI:49â€"89%) than for one-dose MuCV (59%, 95% CI: 36â€"74%. The protection afforded by both one-dose and two-dose MuCV waned over time, from 82% among students vaccinated within 5 years to 41% among those vaccinated more than 10 years previously for one-dose VE, and from 90% to 25% over the same time period for two-dose VE. We found that outbreaks of mumps can occur in schools despite high coverage of one-dose MuCV vaccination. Although the VE of both two-dose and one-dose MuCV wanes over time, the overall VE for two-dose MuCV was superior than that of one-dose MuCV. Therefore, a two-dose MuCV schedule through routine services is likely needed in order to control mumps epidemics in China.

Entities:  

Keywords:  Mumps; outbreak; risk factors; vaccine effectiveness

Mesh:

Substances:

Year:  2019        PMID: 30779678      PMCID: PMC6773387          DOI: 10.1080/21645515.2019.1581526

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  27 in total

1.  The control of mumps in Israel.

Authors:  P E Slater; E Anis; A Leventhal
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

Review 2.  MMR vaccination and disease elimination: the Finnish experience.

Authors:  Irja Davidkin; Mia Kontio; Mikko Paunio; Heikki Peltola
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

Review 3.  Mumps and the UK epidemic 2005.

Authors:  Ravindra K Gupta; Jennifer Best; Eithne MacMahon
Journal:  BMJ       Date:  2005-05-14

4.  Mumps outbreak in Israel's highly vaccinated society: are two doses enough?

Authors:  E Anis; I Grotto; L Moerman; B Warshavsky; P E Slater; B Lev
Journal:  Epidemiol Infect       Date:  2011-04-20       Impact factor: 2.451

5.  Characteristics of Large Mumps Outbreaks in the United States, July 2010-December 2015.

Authors:  Nakia S Clemmons; Susan B Redd; Paul A Gastañaduy; Mona Marin; Manisha Patel; Amy Parker Fiebelkorn
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

6.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

7.  Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.

Authors:  Aili Cui; Zhen Zhu; Naiying Mao; Yuan Si; Yu Ma; Ying Hu; Xiuying Deng; Liping Wang; Lingjia Zeng; Yan Zhang; Wenbo Xu
Journal:  Vaccine       Date:  2018-08-16       Impact factor: 3.641

8.  The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies.

Authors:  W J Edmunds; N J Gay; M Kretzschmar; R G Pebody; H Wachmann
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

9.  Mumps outbreak in Orthodox Jewish communities in the United States.

Authors:  Albert E Barskey; Cynthia Schulte; Jennifer B Rosen; Elizabeth F Handschur; Elizabeth Rausch-Phung; Margaret K Doll; Kisha P Cummings; E Oscar Alleyne; Patricia High; Jacqueline Lawler; Andria Apostolou; Debra Blog; Christopher M Zimmerman; Barbara Montana; Rafael Harpaz; Carole J Hickman; Paul A Rota; Jennifer S Rota; William J Bellini; Kathleen M Gallagher
Journal:  N Engl J Med       Date:  2012-11-01       Impact factor: 91.245

10.  Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.

Authors:  Hong Pang; Yibiao Zhou; Wensui Zhao; Qingwu Jiang
Journal:  Int J Environ Res Public Health       Date:  2018-09-23       Impact factor: 3.390

View more
  5 in total

1.  Effects of extreme meteorological factors on daily mumps cases in Hefei, China, during 2011-2016.

Authors:  Huabing Wu; Enqing You; Chunxiao Jiang; Yuwei Yang; Ling Wang; Qingshan Niu; Xuelei Lu; Fen Huang
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-12       Impact factor: 4.223

2.  Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.

Authors:  Danni Wang; Tingyue Nie; Fan Pan; Yao Wang; Jian Wang; Wei Qin
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452

Review 3.  Mumps Orchitis: Clinical Aspects and Mechanisms.

Authors:  Han Wu; Fei Wang; Dongdong Tang; Daishu Han
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

4.  Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.

Authors:  Zhiying Yin; Canjie Zheng; Quanjun Fang; Xiaoying Gong; Guoping Cao; Junji Li; Ziling Xiang; Wei Song
Journal:  J Immunol Res       Date:  2021-11-05       Impact factor: 4.818

5.  Preponderance of vaccine-preventable diseases hotspots in northern Ghana: a spatial and space-time clustering analysis from 2010 to 2014.

Authors:  Daniel Amoako-Sakyi; Dorcas Obiri-Yeboah; Anthony Ofosu; Kwadwo Asamoah Kusi; Kingsley Osei; Richard Adade; Ebenezer Aniakwaa-Bonsu; Reginald Quansah; John Arko-Mensah; Brodrick Yeboah Amoah; Godwin Kwakye-Nuako; Eric Yaw Frimpong; Mariama Combasseré-Cherif; Hidaya Mohammed; Boubacar Maiga; Julius Fobil; Isabella Quakyi; Ben A Gyan
Journal:  BMC Public Health       Date:  2022-10-12       Impact factor: 4.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.